SYDC_HUMAN - dbPTM
SYDC_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SYDC_HUMAN
UniProt AC P14868
Protein Name Aspartate--tRNA ligase, cytoplasmic
Gene Name DARS
Organism Homo sapiens (Human).
Sequence Length 501
Subcellular Localization Cytoplasm, cytosol .
Protein Description Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA..
Protein Sequence MPSASASRKSQEKPREIMDAAEDYAKERYGISSMIQSQEKPDRVLVRVRDLTIQKADEVVWVRARVHTSRAKGKQCFLVLRQQQFNVQALVAVGDHASKQMVKFAANINKESIVDVEGVVRKVNQKIGSCTQQDVELHVQKIYVISLAEPRLPLQLDDAVRPEAEGEEEGRATVNQDTRLDNRVIDLRTSTSQAVFRLQSGICHLFRETLINKGFVEIQTPKIISAASEGGANVFTVSYFKNNAYLAQSPQLYKQMCICADFEKVFSIGPVFRAEDSNTHRHLTEFVGLDIEMAFNYHYHEVMEEIADTMVQIFKGLQERFQTEIQTVNKQFPCEPFKFLEPTLRLEYCEALAMLREAGVEMGDEDDLSTPNEKLLGHLVKEKYDTDFYILDKYPLAVRPFYTMPDPRNPKQSNSYDMFMRGEEILSGAQRIHDPQLLTERALHHGIDLEKIKAYIDSFRFGAPPHAGGGIGLERVTMLFLGLHNVRQTSMFPRDPKRLTP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MPSASASRKS
-----CCCHHCCCCC
33.2929759185
5Phosphorylation---MPSASASRKSQE
---CCCHHCCCCCCC
30.9923312004
7Phosphorylation-MPSASASRKSQEKP
-CCCHHCCCCCCCCC
37.4325106551
10PhosphorylationSASASRKSQEKPREI
CHHCCCCCCCCCHHH
42.3228450419
13UbiquitinationASRKSQEKPREIMDA
CCCCCCCCCHHHHHH
41.56-
18SulfoxidationQEKPREIMDAAEDYA
CCCCHHHHHHHHHHH
2.1621406390
24PhosphorylationIMDAAEDYAKERYGI
HHHHHHHHHHHHHCH
15.8620071362
26AcetylationDAAEDYAKERYGISS
HHHHHHHHHHHCHHH
36.1723236377
26MalonylationDAAEDYAKERYGISS
HHHHHHHHHHHCHHH
36.1726320211
26UbiquitinationDAAEDYAKERYGISS
HHHHHHHHHHHCHHH
36.17-
29PhosphorylationEDYAKERYGISSMIQ
HHHHHHHHCHHHHHC
21.6529449344
32PhosphorylationAKERYGISSMIQSQE
HHHHHCHHHHHCCCC
14.9728857561
33PhosphorylationKERYGISSMIQSQEK
HHHHCHHHHHCCCCC
20.2728857561
34SulfoxidationERYGISSMIQSQEKP
HHHCHHHHHCCCCCC
2.2930846556
37PhosphorylationGISSMIQSQEKPDRV
CHHHHHCCCCCCCCE
29.4029449344
40AcetylationSMIQSQEKPDRVLVR
HHHCCCCCCCCEEEE
44.5823236377
40UbiquitinationSMIQSQEKPDRVLVR
HHHCCCCCCCCEEEE
44.58-
43MethylationQSQEKPDRVLVRVRD
CCCCCCCCEEEEEEE
32.00-
52PhosphorylationLVRVRDLTIQKADEV
EEEEEECEECCCCEE
26.1730266825
55AcetylationVRDLTIQKADEVVWV
EEECEECCCCEEEEE
54.6957530815
63MethylationADEVVWVRARVHTSR
CCEEEEEEEEEECHH
10.85-
74MalonylationHTSRAKGKQCFLVLR
ECHHCCCCEEEEEEE
43.0926320211
74UbiquitinationHTSRAKGKQCFLVLR
ECHHCCCCEEEEEEE
43.0919608861
74AcetylationHTSRAKGKQCFLVLR
ECHHCCCCEEEEEEE
43.0919608861
99AcetylationAVGDHASKQMVKFAA
EECCHHHHHHHHHHH
43.1025953088
99UbiquitinationAVGDHASKQMVKFAA
EECCHHHHHHHHHHH
43.1021890473
99UbiquitinationAVGDHASKQMVKFAA
EECCHHHHHHHHHHH
43.1021890473
103UbiquitinationHASKQMVKFAANINK
HHHHHHHHHHHCCCH
24.7621890473
103AcetylationHASKQMVKFAANINK
HHHHHHHHHHHCCCH
24.7623954790
103MalonylationHASKQMVKFAANINK
HHHHHHHHHHHCCCH
24.7626320211
103UbiquitinationHASKQMVKFAANINK
HHHHHHHHHHHCCCH
24.7621890473
110AcetylationKFAANINKESIVDVE
HHHHCCCHHHCCCHH
49.3819816139
110UbiquitinationKFAANINKESIVDVE
HHHHCCCHHHCCCHH
49.38-
112PhosphorylationAANINKESIVDVEGV
HHCCCHHHCCCHHHH
29.5321406692
1262-HydroxyisobutyrylationVVRKVNQKIGSCTQQ
HHHHHHHHHCCCCHH
43.78-
126AcetylationVVRKVNQKIGSCTQQ
HHHHHHHHHCCCCHH
43.7825953088
126UbiquitinationVVRKVNQKIGSCTQQ
HHHHHHHHHCCCCHH
43.78-
130GlutathionylationVNQKIGSCTQQDVEL
HHHHHCCCCHHHHHH
3.1622555962
143PhosphorylationELHVQKIYVISLAEP
HHEEEEEEEEECCCC
9.9628152594
146PhosphorylationVQKIYVISLAEPRLP
EEEEEEEECCCCCCC
16.1020068231
188MethylationDNRVIDLRTSTSQAV
CCEEEEECCCCHHHH
23.92-
200PhosphorylationQAVFRLQSGICHLFR
HHHHHHHHHHHHHHH
34.4221210654
2132-HydroxyisobutyrylationFRETLINKGFVEIQT
HHHHHHHCCCEEECC
46.89-
213AcetylationFRETLINKGFVEIQT
HHHHHHHCCCEEECC
46.8957530807
220PhosphorylationKGFVEIQTPKIISAA
CCCEEECCCCEEEEC
32.0124702127
225PhosphorylationIQTPKIISAASEGGA
ECCCCEEEECCCCCC
22.6620068231
228PhosphorylationPKIISAASEGGANVF
CCEEEECCCCCCCEE
36.1721406692
236PhosphorylationEGGANVFTVSYFKNN
CCCCCEEEEEEECCC
12.3128152594
238PhosphorylationGANVFTVSYFKNNAY
CCCEEEEEEECCCEE
23.0728152594
239PhosphorylationANVFTVSYFKNNAYL
CCEEEEEEECCCEEE
17.7828152594
241AcetylationVFTVSYFKNNAYLAQ
EEEEEEECCCEEECC
40.8557530811
241UbiquitinationVFTVSYFKNNAYLAQ
EEEEEEECCCEEECC
40.85-
245PhosphorylationSYFKNNAYLAQSPQL
EEECCCEEECCCHHH
12.5128152594
249PhosphorylationNNAYLAQSPQLYKQM
CCEEECCCHHHHHHH
14.7019664994
253PhosphorylationLAQSPQLYKQMCICA
ECCCHHHHHHHHHHC
8.2323403867
254AcetylationAQSPQLYKQMCICAD
CCCHHHHHHHHHHCC
39.9026051181
274AcetylationSIGPVFRAEDSNTHR
EECCEEECCCCCCCC
17.3019608861
274UbiquitinationSIGPVFRAEDSNTHR
EECCEEECCCCCCCC
17.3019608861
323PhosphorylationGLQERFQTEIQTVNK
HHHHHHHHHHHHHHH
32.1320068231
327PhosphorylationRFQTEIQTVNKQFPC
HHHHHHHHHHHCCCC
31.5420068231
330UbiquitinationTEIQTVNKQFPCEPF
HHHHHHHHCCCCCCC
49.3221890473
330AcetylationTEIQTVNKQFPCEPF
HHHHHHHHCCCCCCC
49.3225953088
330UbiquitinationTEIQTVNKQFPCEPF
HHHHHHHHCCCCCCC
49.3221890473
338UbiquitinationQFPCEPFKFLEPTLR
CCCCCCCCCCCCCHH
60.81-
343PhosphorylationPFKFLEPTLRLEYCE
CCCCCCCCHHHHHHH
18.3521712546
362SulfoxidationLREAGVEMGDEDDLS
HHHHCCCCCCCCCCC
8.3428183972
369PhosphorylationMGDEDDLSTPNEKLL
CCCCCCCCCCCHHHH
49.14-
370PhosphorylationGDEDDLSTPNEKLLG
CCCCCCCCCCHHHHH
37.1128985074
374AcetylationDLSTPNEKLLGHLVK
CCCCCCHHHHHHHHH
56.5019608861
374UbiquitinationDLSTPNEKLLGHLVK
CCCCCCHHHHHHHHH
56.5021906983
381UbiquitinationKLLGHLVKEKYDTDF
HHHHHHHHHHCCCCE
55.65-
383UbiquitinationLGHLVKEKYDTDFYI
HHHHHHHHCCCCEEE
42.58-
3832-HydroxyisobutyrylationLGHLVKEKYDTDFYI
HHHHHHHHCCCCEEE
42.58-
383AcetylationLGHLVKEKYDTDFYI
HHHHHHHHCCCCEEE
42.5827452117
384PhosphorylationGHLVKEKYDTDFYIL
HHHHHHHCCCCEEEE
25.7625884760
386PhosphorylationLVKEKYDTDFYILDK
HHHHHCCCCEEEEEC
25.56-
389PhosphorylationEKYDTDFYILDKYPL
HHCCCCEEEEECCCC
11.9125884760
393UbiquitinationTDFYILDKYPLAVRP
CCEEEEECCCCEEEC
45.37-
394PhosphorylationDFYILDKYPLAVRPF
CEEEEECCCCEEECC
11.8024719451
402PhosphorylationPLAVRPFYTMPDPRN
CCEEECCCCCCCCCC
12.5725884760
403PhosphorylationLAVRPFYTMPDPRNP
CEEECCCCCCCCCCC
23.7024719451
411AcetylationMPDPRNPKQSNSYDM
CCCCCCCCCCCCCCC
70.6625953088
411UbiquitinationMPDPRNPKQSNSYDM
CCCCCCCCCCCCCCC
70.66-
413PhosphorylationDPRNPKQSNSYDMFM
CCCCCCCCCCCCCHH
33.5921406692
415PhosphorylationRNPKQSNSYDMFMRG
CCCCCCCCCCCHHCH
27.9721406692
416PhosphorylationNPKQSNSYDMFMRGE
CCCCCCCCCCHHCHH
18.7121406692
427PhosphorylationMRGEEILSGAQRIHD
HCHHHHHHHHCCCCC
37.4321406692
451AcetylationHHGIDLEKIKAYIDS
HCCCCHHHHHHHHHH
57.7223954790
4512-HydroxyisobutyrylationHHGIDLEKIKAYIDS
HCCCCHHHHHHHHHH
57.72-
451UbiquitinationHHGIDLEKIKAYIDS
HCCCCHHHHHHHHHH
57.72-
4532-HydroxyisobutyrylationGIDLEKIKAYIDSFR
CCCHHHHHHHHHHHC
46.32-
453AcetylationGIDLEKIKAYIDSFR
CCCHHHHHHHHHHHC
46.3257530803
453UbiquitinationGIDLEKIKAYIDSFR
CCCHHHHHHHHHHHC
46.32-
478SulfoxidationIGLERVTMLFLGLHN
CCHHHHHHHHHCCCC
1.9728183972
490PhosphorylationLHNVRQTSMFPRDPK
CCCCCCCCCCCCCCC
15.3028857561
500PhosphorylationPRDPKRLTP------
CCCCCCCCC------
30.8724719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
500TPhosphorylationKinasePKA-Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SYDC_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SYDC_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
AIMP2_HUMANAIMP2physical
16189514
EF1A1_HUMANEEF1A1physical
7806521
SYIC_HUMANIARSphysical
22939629
SYMC_HUMANMARSphysical
22939629
SYEP_HUMANEPRSphysical
22939629
SYRC_HUMANRARSphysical
22939629
SYQ_HUMANQARSphysical
22939629
SYLC_HUMANLARSphysical
22939629
SYK_HUMANKARSphysical
22939629
GARS_HUMANGARSphysical
22939629
VATB2_HUMANATP6V1B2physical
22939629
XPO2_HUMANCSE1Lphysical
22939629
TRM1_HUMANTRMT1physical
22939629
TLN1_HUMANTLN1physical
22939629
XPP1_HUMANXPNPEP1physical
22939629
VATA_HUMANATP6V1Aphysical
22939629
AIMP1_HUMANAIMP1physical
22863883
AIMP2_HUMANAIMP2physical
22863883
SYIC_HUMANIARSphysical
22863883
SYMC_HUMANMARSphysical
22863883
PSA5_HUMANPSMA5physical
22863883
SYQ_HUMANQARSphysical
22863883
RL23A_HUMANRPL23Aphysical
22863883
RL26_HUMANRPL26physical
22863883
RL36_HUMANRPL36physical
22863883
AIMP2_HUMANAIMP2physical
25416956
AIMP1_HUMANAIMP1physical
26344197
AIMP2_HUMANAIMP2physical
26344197
PYR1_HUMANCADphysical
26344197
CALX_HUMANCANXphysical
26344197
MCA3_HUMANEEF1E1physical
26344197
SYEP_HUMANEPRSphysical
26344197
GFPT1_HUMANGFPT1physical
26344197
SYIC_HUMANIARSphysical
26344197
SYLC_HUMANLARSphysical
26344197
SYMC_HUMANMARSphysical
26344197
OTU6A_HUMANOTUD6Aphysical
26344197
SYQ_HUMANQARSphysical
26344197
RFA2_HUMANRPA2physical
26344197
TIAM1_HUMANTIAM1physical
26344197
ZN598_HUMANZNF598physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
615281Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00128L-Aspartic Acid
Regulatory Network of SYDC_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-74 AND LYS-374, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND MASSSPECTROMETRY.

TOP